The "CONSORT" guidelines for randomized controlled trials in Obstetrics & Gynecology

Obstetrics and Gynecology

Volumn 100, Issue 4, 2002, Pages 631-632

  Grimes, David A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FOLLOW UP; GYNECOLOGY; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; OBSTETRICS; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCIENTIFIC LITERATURE; SHORT SURVEY;

EID: 0036804022     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02233-0     Document Type: Editorial

References (14)

1. Grimes D.A. Clinical research in ancient Babylon Methodologic insights from the book of Daniel . Obstet Gynecol. 86:1995;1031-1034.
2. Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of pulmonary tuberculosis. BMJ. 2:1948;769-782.
3. Funai E.F., Rosenbush E.J., Lee M.J., Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest. 51:2001;8-11.
4. Schulz K.F., Chalmers I., Grimes D.A., Altman D.G. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 272:1994;125-128.
5. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
6. Schulz K.F., Grimes D.A. Sample size slippages in randomised trials Exclusions and the lost and wayward . Lancet. 359:2002;781-785.
7. Altman D.G. Poor-quality medical research What can journals do? JAMA. 287:2002;2765-2767.
8. Grimes D.A., Schulz K.F. Methodology citations and the quality of randomized controlled trials in obstetrics and gynecology. Am J Obstet Gynecol. 174:1996;1312-1315.
9. Moher D., Schulz K.F., Altman D. The CONSORT statement Revised recommendations for improving the quality of reports of parallel-group randomized trials . JAMA. 285:2001;1987-1991.
10. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials Explanation and elaboration . Ann Intern Med. 134:2001;663-694.
11. Standards for reporting randomized trials. 2002;. Available at: http://www.greenjournal.org/CONSORT.pdf. Accessed 2002 Jul 29.
12. Moher D., Jones A., Lepage L. Use of the CONSORT statement and quality of reports of randomized trials A comparative before-and-after evaluation . JAMA. 285:2001;1992-1995.
13. Altman D.G. The scandal of poor medical research. BMJ. 308:1994;283-284.
14. Buyse M., George S.L., Evans S., Geller N.L., Ranstam J., Scherrer B., et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med. 18:1999;3435-3451.